儿童脑震荡的特征因年龄而异
Jonathan Santana1,2, Abigail N Padilla1, Tishya A L Wren1,2,3
1Jackie and Gene Autry Orthopedic Center, Children's Hospital Los Angeles, Los Angeles, USA.
Brain injury
|November 3, 2025
概括
儿童脑震荡因年龄而异. 较小的孩子经常因非运动伤害而遭受脑震荡,并且报告症状较少,而较大的孩子则报告更多的头痛和雾等症状.
科学领域:
- 儿科神经学 儿科神经学
- 运动医学运动医学
- 创伤性脑损伤研究研究
背景情况:
- 儿童脑震荡在诊断和管理方面存在独特的挑战.
- 了解儿科脑震荡的年龄相关差异对于有效的护理至关重要.
研究的目的:
- 调查不同年龄段儿童脑震荡损伤机制和初始症状的变化.
- 为了确定儿童经历和报告脑震荡症状的年龄特定模式.
主要方法:
- 在第三级儿童医院系统中对脑震荡患者 (n=333) 的回顾性分析.
- 患者分为0-7,8-12岁和13岁以上的年龄组.
- 使用克鲁斯卡尔-瓦利斯和费舍尔精确测试对人口统计,损伤和症状数据的统计比较.
主要成果:
- 年龄较小的儿童 (0-7岁) 与年龄较大的儿童相比,更有可能从非运动机制中持续脑震荡 (p < 0.001).
- 较年长的年龄组报告了更高的症状,包括头痛,部疼痛,声音敏感性,感觉减慢,记忆障碍,雾和低能量的流行率 (p <0.05).
- 在老年儿科脑震荡患者组中,男性的比例下降 (p = 0.007).
结论:
- 儿童脑震荡机制和症状呈现在不同年龄段有很大的差异.
- 年龄较小的孩子可能会低于报告症状,可能是因为依赖父母的观察或伤害严重程度较低.
- 适合儿童年龄的症状评估对于准确诊断和治疗儿科脑震荡至关重要.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
185
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
239
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
Drug Dosing: Infants and Children
241
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
241
Conduct Disorder
470
Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
470
Attention-Deficit/Hyperactivity Disorder
733
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
733


